Juniper Investment Company, a 10% owner of Orthofix Medical Inc. (NASDAQ:OFIX), reported selling 242,000 shares of common stock. The transaction occurred on May 22, 2026, totaling approximately $2.59 million.
The shares were sold at a weighted average price of $10.6992 per share, with individual sale prices ranging from $10.2450 and $10.9500. OFIX stock currently trades at $9.27, near its 52-week low of $9.13, declining nearly 12% over the past week. According to Bond.az analysis, the stock appears undervalued at current levels.
Following the sale, Juniper Targeted Opportunity Fund, L.P. beneficially owns 3,461,216 Orthofix shares. Reporting owners John A. Bartholdson and Alexis P. Michas also indirectly hold an additional 935,901 shares via Juniper Targeted Opportunities, L.P., and 45,426 shares via Juniper Multi-Strategy Fund, L.P.
In other recent news, Orthofix Medical reported Q1 2026 earnings. EPS came in at -$0.52, beating the forecast of -$0.61. Revenue reached $196.71 million, surpassing expectations. Medicare reimbursement for non-invasive bone growth stimulators is expected to decline by approximately 10%. The company revised its 2026 guidance: net sales between $838M and $848M, adjusted EBITDA between $90M and $93M.
